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Abstract
Background: Data on the effect of contraceptive methods, other than the condom, on HIV
acquisition is not clear. The aim of this study was to describe hormonal contraceptive use, sexual
behaviour and HIV prevalence among women in Cameroon in order to provide baseline
information for future analytical studies.
Methods: This is a cross-sectional descriptive study based a nationally representative sample of
4486 sexually active women aged 15–49 years who participated in the 2004 Cameroon
Demographic and Health Survey.
Results: The overall HIV prevalence was 7.4% (332/4486). The HIV prevalence was higher in the
25–35 year age group (10.03%), urban residents (9.39%), and formerly married (18.48%), compared
to their compatriots. The prevalence was lower in women with five or more living child (3.67%),
women in the low wealth index category (3.79%) and women who had no formal education
(3.37%). The HIV prevalence was higher among women who had two or more partners in the last
12 months (10.26%) and women who reported to have had four or more partners in their lifetime
(12.40%). The prevalence of HIV was higher among current hormonal contraceptive users (6.63%)
compared to the current non-users (3.06%), among ever users of hormonal contraception
(13.27%) compared to the never users (7.11%).
Conclusion: We conclude that the prevalence of HIV among sexually active women in Cameroon
varies according to sociodemographic characteristics, sexual behaviour and hormonal
contraceptive use. Our findings underscore the need to counsel women using hormonal
contraception to be aware that hormonal methods do not protect against HIV infection. Given the
biologic plausibility of the link between hormonal contraception and HIV infection, future research
should focus on carefully designed prospective studies to establish the temporal relationship and
estimate the incidence of HIV infection among women using and not using hormonal contraceptive
methods.
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Background
Acquired Immunodeficiency Syndrome (AIDS) has
claimed more than 25 million lives since its discovery in
1981 [1]. Today, about 33.2 million people live with
Human Immunodeficiency Virus (HIV) – the virus that
causes AIDS – infections. Sub-Saharan Africa has just over
10% of the world's population, but 64% of people living
with HIV, and 77% of all women with HIV worldwide live
in this region [1,2]. Cameroon is one of the hardest-hit
countries in Sub-Saharan Africa with an overall adult
prevalence of 5.5% [3].
The main mode of HIV transmission in Sub-Saharan
Africa is via heterosexual sex. The major factors associated
with HIV transmission include the presence of other sexu-
ally transmitted infections (STIs), and sexual risk behav-
iors, such as multiple sexual partnerships, commercial sex,
and the non-use of condoms. These behaviors are affected
by the individual lack of knowledge about HIV, ignorance
of individual HIV status, beliefs about HIV/AIDS, cultural
factors such as female circumcision, widow inheritance, as
well as by societal structural factors such as poverty,
migration, or gender inequalities [4-6].
Less is known about the effect of various contraceptive
methods on the risk of HIV acquisition. Recent evidence
suggests that some contraceptive methods could be pro-
tective against HIV infection while others could increase
the risk of HIV transmission [7-12]. However, apart from
the condom which has demonstrated substantial protec-
tion against HIV infection, the effect of the other methods
on HIV transmission remains largely unknown [8,9]. The-
oretically, hormonal contraceptives could predispose
women to HIV infection by increasing vaginal HIV recep-
tors [10], causing thinning of the vaginal epithelium [11],
or increasing the risk of chlamydial infection [2].
The aim of the current study was to describe hormonal
contraceptive use, sexual behaviour and HIV prevalence
among women in Cameroon in order to provide baseline
information for future analytical studies.
Methods
Study Design
This cross-sectional descriptive study is based on data
from the 2004 DHS. The survey was approved by the Eth-
ics Committee of the ORC Macro at Calverton, Maryland,
USA and by the National Ethics Committee in the Minis-
try of Health in Cameroon. All study participants gave
informed consent before participation and all informa-
tion was collected confidentially.
Sampling technique
Methods used in the Cameroon DHS have been published
elsewhere [3]. Briefly, the survey used a two-stage cluster
sampling technique. The country was stratified into 12
domains (10 provinces and 2 major cities). Each domain
is made up of enumeration areas (EAs) established by a
General Census of Population and Housing in 2003. The
sample frame was a list of all EAs (clusters). Within each
domain, a two-stage sample was selected. The first stage
involved selecting 466 clusters (EAs – primary sampling
units) with a probability proportional to the number of
households in the cluster. The second stage involved the
systematic sampling of households from the selected clus-
ters. All women aged 15 to 49 years in the selected house-
holds were interviewed.
Study population
Of the total 10656 women who participated in the survey,
4,538 sexually active women were also tested for HIV and
all are included in the current study.
Data Collection
After obtaining an informed consent from the women,
data were collected by face-to-face interviews at home
using a structured questionnaire. Blood sample for HIV
testing was drawn after the interview. For the current study
we extracted information on sociodemographic character-
istics, sexual behavior, contraceptive use and HIV status.
Variables
We used six characteristics to define socio-demographic
characteristics: (a) age (15–24, 25–34 or 35–49 years), (b)
place of residence (rural or urban), (c) marital status
(never married, currently married, divorced/widowed),
(d) number of children (0, 1–2, 3–4 or ≥ 5), (e) education
(no schooling, primary and secondary/higher) and (f)
wealth index (low, middle or high). Wealth index was
defined based on the availability of some household
amenities. A score was attributed to each household
amenity and the total score constituted the wealth index
score [13]. We divided this score into three equal classes
of wealth based percentiles, that is, less than 33.33th per-
centile (low, i.e. poorest), 33.33 to 66.66th percentile
(medium, i.e. moderately rich), and more than 66.66th
percentile (high, i.e. richest).
Sexual behavior was defined by three variables: (a) age at
sexual debut (≤ 14, 15–17 or ≥ 18 years; (b) number of
sexual partners in the last 12 months (0, 1 and ≥ 2 part-
ners); and (c) life number of partners (1, 2–3 and ≥ 4 part-
ners).
Two variables were used to define hormonal contraceptive
use: (a) current use (current user or current non-user) and
(b) ever use (ever user or never user). Current user referred
to a woman was using the contraceptive at the time of
interview, and ever user referred to a woman who had
taken the contraceptive at any one point in time since sex-BMC Women's Health 2008, 8:19 http://www.biomedcentral.com/1472-6874/8/19
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ual debut including the time when she was interviewed.
Hormonal contraception was defined as the use of oral
contraceptive pills, injectable contraceptives or implants.
HIV status was determined by the positive or negative
results of the HIV test, based on the presence of specific
anti-HIV antibodies in the blood sample. Direct ELISA
(Genscreen Plus version, BioRad Laboratories) was used
to screen for both HIV1 and HIV2. Positive results were
confirmed by competitive ELISA (Wellcozyme HIV-1
recombinant, ABBOTT) specific for HIV-1 and a rapid test
(Determine, ABBOTT) specific for HIV-2. All positive and
doubtful results were finally confirmed with the Western
Blot test.
Statistical analyses
All cases in the DHS data were given weights to adjust for
differences in probability of selection of subjects and to
adjust for the non-response in order to produce a proper
representation of the whole country [3]. The weight is
determined such that it is inversely proportional to the
response rate as well as the probability of selection. There-
fore, the use of weights corrects for the differential
response rates and the unequal probability used to select
subjects in the sample. We used individual weights data
analysis in this study.
Data were entered and analyzed with the Statistical Pack-
age for Social Sciences (SPSS) software programme (ver-
sion 15.0, Chicago, IL, USA). The prevalence of HIV was
determined for different categories of socio-demographic
variables, sexual behaviour and hormonal contraceptive
use. The results were expressed in terms of proportions or
percentages with their corresponding 95% Confidence
Intervals (CI).
Results
Of the 4486 women who participated in the study, 332
(7.4%) were HIV positive, 136 (3.0%) were current hor-
monal contraceptive users and 211 (4.7%) were ever users
of hormonal contraception.
Socio-demographic characteristics
The prevalence of HIV was higher in the 25–35 year age
group (10.03%, 95% Confidence Interval [CI] 8.59 to
11.63), compared to the 15–24 year age group (5.91%,
95%CI 4.88 to 7.10) and 35–49 year age group (6.38%,
95%CI 5.11 to 7.84). HIV prevalence was higher among
women who lived in the urban area (9.39%, 95%CI 8.27
to 10.60%), compared to women who lived in the rural
area (5.10%, 95%CI 4.22 to 6.11). HIV prevalence was
18.48% (95%CI 15.03 to 22.34) among formerly married
(widowed and divorced) and this figure was 3-fold higher
than the prevalence among never married and currently
married women. The HIV prevalence was lower in women
with five or more living child (3.67%, 95%CI 2.62 to
4.99), women in the low wealth index category (3.79%,
95%CI 2.92 to 4.83) and women who had no formal edu-
cation (3.37%, 95%CI 2.41 to 4.59), compared to women
with fewer children, middle and higher wealth index and
women who had been to school respectively. Table 1
presents the distribution of socio-demographic character-
istics by HIV prevalence among women in Cameroon.
Sexual behavior
The HIV prevalence was higher among women who had
two or more partners in the last 12 months (10.26%,
95%CI 7.24 to 14.00) compared to their compatriots with
zero or one partner (Table 1). Similarly, the HIV preva-
lence was higher in women who had had four or more
partners in their lifetime (12.40%, 95%CI 10.65 to 14.33)
compared to women with fewer number of lifetime sexual
partners. The HIV prevalence did not differ by age at sex-
ual debut among women of reproductive age.
Hormonal contraceptive use
The prevalence of HIV was higher among current hormo-
nal contraceptive users (6.63%, 95%CI 3.28 to 11.79)
compared to the current non-users (3.06%, 9%CI 2.57 to
3.61). Similarly, the prevalence of HIV was higher among
the ever users of hormonal contraception (13.27%,
95%CI 9.18 to 18.36%) compared to the never users
(7.11%, 95%CI 6.37% to 7.91).
Discussion
In this study we sought to describe the distribution of
socio-demographic characteristics, sexual behaviour and
hormonal contractive use by HIV status among women of
reproductive age in Cameroon using data from a popula-
tion-based nationally representative survey. The use of
hormonal contraception among the women was low
(3.0%) and HIV prevalence rate (7.4%) was higher than
previously reported [3], due in part that the current study
included only sexually active women.
The low level of hormonal contraceptive use among Cam-
eroonian women of reproductive age was expected, based
on the known high fertility rate in Cameroon: 176 births
per 1000 women aged 15 to 44 years [3]. Similar low rates
of contraceptive use have been reported in other sub-
Saharan African countries, ranging from as low as 2.5% in
Chad to 25.7% in Malawi [14,15]. Therefore there is need
for more easily accessible family planning services and
education of women and men about family planning in
Cameroon.
In the current study HIV prevalence was found to higher
among formerly married women, women living in urban
areas and 25–34 year age group. These findings are similar
to findings of previous studies in other African countriesBMC Women's Health 2008, 8:19 http://www.biomedcentral.com/1472-6874/8/19
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[16,17]. We found the HIV prevalence to be higher among
educated women which is similar to the findings of one
study [18], but differed from the findings of another study
[17]. The findings of the current study affirm the known
significant positive correlation between the number of
wealth and sexual partners on the one hand and the risk
of HIV infection of the other hand [19,20].
The current study found the HIV prevalence to be higher
among current and ever users of hormonal contraceptives,
compared to their compatriots. One cross-sectional study
found a significantly higher HIV prevalence among
women on depo-medroxyprogesterone acetate (DMPA)
and oral contraceptives in four countries in Africa [21].
However evidence from prospective cohort studies sug-
gests that DMPA and oral contraceptives are not associ-
ated with increased risk of HIV infection [9,22]. Current
evidence suggests that there is no overall risk of HIV-1
acquisition among women taking hormonal contracep-
tion [23]. To date no randomized controlled trials have
been conducted because of arguments that randomizing
women who desire hormonal contraceptive could be
Table 1: The distribution of socio-demographics, sexual behaviour and hormonal contraceptive use by HIV status among 
Cameroonian women (N = 4486)
HIV Positive
Variable Number Percent 95% Confidence interval
1. Socio-demographic
Age (years)
15–24 103/1742 5.91 4.88–7.10
25–34 151/1505 10.03 8.59–11.63
35–49 79/1239 6.38 5.11–7.84
Place of residence
Rural 106/2078 5.10 4.22–6.11
Urban 226/2407 9.39 8.27–10.60
Marital status
Never married 37/566 6.54 4.71–8.81
Currently married 215/3487 6.17 5.40–7.00
Formerly married 80/433 18.48 15.03–22.34
No. of living children
0 84/952 8.82 7.14–10.75
1–2 146/1575 9.27 7.91–10.78
3–4 69/978 7.06 5.57–8.79
≥ 5 36/982 3.67 2.62–4.99
Wealth index
Low 59/1557 3.79 2.92–4.83
Middle 142/1520 9.34 7.95–10.88
High 132/1409 9.37 7.93–10.97
Educational level
No schooling 36/1067 3.37 2.41–4.59
Primary 146/1767 8.26 7.05–9.62
Secondary or higher 155/1811 8.56 7.34–9.91
2. Sexual behaviours
No. of partners in the last 12 months
0 52/594 8.75 6.68–11.23
1 248/3578 6.93 6.13–7.80
≥ 2 32/312 10.26 7.24–14.00
Lifetime No. of partners
1 41/1616 2.54 1.85–3.39
2–3 137/1629 8.41 7.13–9.83
≥ 4 153/1234 12.40 10.65–14.33
3. Hormonal contraception
Current hormonal contraceptive use
Current non-users 127/4154 3.06 2.57–3.61
Current users 9/136 6.62 3.28–11.79
Ever use of hormonal contraception
Never users 304/4275 7.11 6.37–7.91
Ever users 28/211 13.27 9.18–18.36BMC Women's Health 2008, 8:19 http://www.biomedcentral.com/1472-6874/8/19
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unethical [23]. Therefore the potential for hormonal con-
traception to increase HIV acquisition remains unclear.
The methodology of the current study poses some limita-
tions. Self-reported use of hormonal contraception and
sexual behavior may be biased in ways that affect the prev-
alence of HIV among different groups. Furthermore, all
hormonal contraceptives were put into one category
although HIV prevalence may differ from one type of hor-
monal contraceptive to another.
Despite these limitations, this study has several strengths.
Firstly, the study population is a national representative
sample which allows generalization of the findings to all
Cameroonian women of reproductive age. Lastly, many of
the previous studies relied on rapid tests for HIV determi-
nation. Our study however used two ELISA tests followed
by confirmation with Western Blot.
Conclusion
In conclusion, we found that the prevalence of HIV in
women of reproductive age was higher among urban resi-
dents, formerly married, wealthier women, educated
women, women with 2 or more partners and current users
of hormonal contraception, compared to their compatri-
ots. The findings, however, have several important impli-
cations for practice and further research: (a) women in
Cameroon using hormonal contraception should be well
informed that the hormonal methods do not protect
against HIV infection; (b) prevention efforts should be
focused on skills training in proper use of condoms, con-
solidating consistent condom use and preventing relapse,
not only raising awareness; (c) future research should
focus on carefully designed prospective studies to estab-
lish the temporal relationship and estimate the incidence
of HIV infection among women using different contracep-
tive methods.
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